Zhao P, Zhang L, Grillo J et al (2011) Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review
Studies on the impact of GLP-1 agonists in psoriatic patients with type 2 diabetes and/or obesity, suggest benefit, but these trials are very small and as yet do not allow of any firm conclusions
This year, he was part of a team that conducted a review on a group of peptides that may be able to help patients recovering from orthopedic sports injuries, including BPC-157 and TB-500
P-Coumaric Acid Reverses Depression-Like Behavior and Memory Deficit Via Inhibiting AGE-RAGE-Mediated Neuroinflammation
Individuals using semaglutide GLP-1 under medical supervision experience positive outcomes such as reduced food cravings, more energy, better sleep, and stable blood sugar levels